Your browser is no longer supported. Please, upgrade your browser.
VIR [NASD]
Vir Biotechnology, Inc.
Index- P/E- EPS (ttm)-6.40 Insider Own0.30% Shs Outstand125.81M Perf Week11.07%
Market Cap4.79B Forward P/E- EPS next Y-2.43 Insider Trans-38.02% Shs Float109.35M Perf Month30.95%
Income-256.80M PEG- EPS next Q-0.71 Inst Own79.60% Short Float12.23% Perf Quarter17.24%
Sales75.60M P/S63.40 EPS this Y-443.30% Inst Trans0.10% Short Ratio12.97 Perf Half Y-17.44%
Book/sh6.46 P/B6.27 EPS next Y-2.50% ROA-39.40% Target Price54.86 Perf Year138.69%
Cash/sh6.99 P/C5.80 EPS next 5Y8.50% ROE-47.10% 52W Range16.09 - 75.00 Perf YTD51.34%
Dividend- P/FCF- EPS past 5Y- ROI-41.90% 52W High-45.96% Beta-
Dividend %- Quick Ratio11.00 Sales past 5Y- Gross Margin- 52W Low151.90% ATR2.86
Employees297 Current Ratio11.00 Sales Q/Q35.70% Oper. Margin- RSI (14)66.72 Volatility9.27% 8.76%
OptionableYes Debt/Eq0.00 EPS Q/Q-52.30% Profit Margin- Rel Volume1.03 Prev Close42.40
ShortableYes LT Debt/Eq0.00 EarningsNov 10 AMC Payout- Avg Volume1.03M Price40.53
Recom2.40 SMA2027.41% SMA5032.81% SMA20011.67% Volume1,057,857 Change-4.41%
Jan-20-21Reiterated H.C. Wainwright Buy $100 → $125
Oct-05-20Initiated BofA Securities Buy $55
Sep-14-20Upgrade Goldman Neutral → Buy $48 → $54
Sep-11-20Upgrade JP Morgan Underweight → Neutral $29
Aug-20-20Initiated Needham Buy $62
Mar-19-20Downgrade JP Morgan Neutral → Underweight $26
Mar-13-20Downgrade Goldman Buy → Neutral
Feb-27-20Downgrade Robert W. Baird Neutral → Underperform $17
Feb-04-20Downgrade JP Morgan Overweight → Neutral $25 → $26
Nov-14-19Initiated Robert W. Baird Neutral
Nov-05-19Initiated JP Morgan Overweight $25
Nov-05-19Initiated Goldman Buy $37
Nov-05-19Initiated Cowen Outperform
Nov-05-19Initiated Barclays Overweight $25
Jan-20-21 01:43PM  
Jan-13-21 02:11PM  
10:00AM  
Jan-12-21 04:31PM  
03:26PM  
08:00AM  
03:00AM  
Jan-06-21 08:00AM  
Jan-05-21 08:00AM  
Dec-22-20 11:00AM  
Dec-18-20 09:12AM  
07:45AM  
Dec-17-20 04:01PM  
Dec-10-20 08:00AM  
Dec-08-20 01:09PM  
Dec-04-20 10:11AM  
Dec-02-20 03:51PM  
Nov-24-20 09:47AM  
Nov-16-20 02:55AM  
Nov-13-20 09:08AM  
Nov-10-20 04:01PM  
Nov-06-20 08:00AM  
Oct-27-20 04:01PM  
Oct-21-20 08:00AM  
Oct-13-20 04:01PM  
11:26AM  
Oct-12-20 09:31AM  
Oct-09-20 08:00AM  
Oct-07-20 01:44PM  
01:01PM  
08:47AM  
07:24AM  
Oct-06-20 04:25PM  
11:28AM  
10:46AM  
10:03AM  
09:49AM  
08:18AM  
Sep-29-20 06:08PM  
Sep-26-20 06:16AM  
Sep-24-20 08:00AM  
Sep-23-20 12:41PM  
Sep-22-20 10:01AM  
09:43AM  
Sep-15-20 06:30AM  
Sep-09-20 04:10PM  
Sep-08-20 04:01PM  
Sep-02-20 07:25AM  
Sep-01-20 04:01PM  
09:39AM  
09:09AM  
Aug-31-20 03:39PM  
03:17PM  
12:45PM  
08:50AM  
08:00AM  
Aug-20-20 09:51AM  
08:00AM  
Aug-11-20 04:01PM  
06:40AM  
Jul-28-20 04:01PM  
Jul-10-20 04:02PM  
04:01PM  
Jul-07-20 10:25PM  
05:58PM  
Jul-06-20 07:00AM  
Jun-08-20 02:06PM  
Jun-05-20 01:22PM  
Jun-04-20 03:57PM  
Jun-02-20 08:00AM  
Jun-01-20 12:23PM  
11:00AM  
May-29-20 08:00AM  
May-27-20 08:00AM  
May-23-20 08:13AM  
May-19-20 09:31AM  
May-18-20 05:28PM  
05:00PM  
02:47PM  
05:05AM  
May-15-20 03:09PM  
01:03PM  
May-12-20 04:01PM  
May-08-20 04:01PM  
May-07-20 04:01PM  
May-05-20 03:26PM  
03:11PM  
May-04-20 10:23AM  
08:24AM  
07:30AM  
Apr-28-20 08:00AM  
Apr-16-20 08:09AM  
Apr-15-20 04:01PM  
Apr-08-20 10:05AM  
07:00AM  
Apr-07-20 11:00AM  
Apr-06-20 04:03PM  
09:56AM  
08:12AM  
08:01AM  
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; a collaboration with WuXi Biologics; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Virgin HerbertEVP, Research & CSOJan 15Option Exercise1.5310,53016,11143,730Jan 19 05:00 PM
Virgin HerbertEVP, Research & CSOJan 15Sale38.0010,530400,14033,200Jan 19 05:00 PM
Virgin HerbertEVP, Research & CSOJan 12Option Exercise1.533,8055,82237,005Jan 13 06:38 PM
Virgin HerbertEVP, Research & CSOJan 12Sale29.363,805111,69633,200Jan 13 06:38 PM
Parrish JayChief Business OfficerJan 04Option Exercise1.496,94510,313229,167Jan 05 04:40 PM
Parrish JayChief Business OfficerJan 04Sale26.326,945182,795222,222Jan 05 04:40 PM
Virgin HerbertEVP, Research & CSODec 24Option Exercise1.539,50014,53533,200Dec 28 06:39 PM
Virgin HerbertEVP, Research & CSODec 22Option Exercise1.533,8055,82227,505Dec 23 06:06 PM
Virgin HerbertEVP, Research & CSODec 22Sale31.193,805118,68323,700Dec 23 06:06 PM
Virgin HerbertEVP, Research & CSODec 08Option Exercise1.533,8055,82227,505Dec 10 05:00 PM
Virgin HerbertEVP, Research & CSODec 08Sale31.273,805118,96623,700Dec 10 05:00 PM
Parrish JayChief Business OfficerDec 01Option Exercise1.526,94510,522229,167Dec 02 05:48 PM
Parrish JayChief Business OfficerDec 01Sale31.536,945218,968222,222Dec 02 05:48 PM
Virgin HerbertEVP, Research & CSONov 27Option Exercise1.532,9304,48326,630Dec 01 07:02 PM
Pang PhillipChief Medical OfficerNov 27Option Exercise0.867,5006,41357,277Dec 01 07:03 PM
Virgin HerbertEVP, Research & CSONov 27Sale30.002,93087,90023,700Dec 01 07:02 PM
Virgin HerbertEVP, Research & CSONov 24Option Exercise1.532,3403,58026,040Nov 25 05:00 PM
Virgin HerbertEVP, Research & CSONov 24Sale27.292,34063,84823,700Nov 25 05:00 PM
Pang PhillipChief Medical OfficerNov 12Option Exercise0.8620,00017,10049,777Nov 16 05:00 PM
Virgin HerbertEVP, Research & CSONov 10Option Exercise1.532,3403,58026,040Nov 12 05:00 PM
Virgin HerbertEVP, Research & CSONov 10Sale26.262,34061,44823,700Nov 12 05:00 PM
Pang PhillipChief Medical OfficerNov 04Option Exercise1.535,0007,65034,777Nov 05 05:00 PM
Parrish JayChief Business OfficerNov 02Option Exercise1.526,94410,520229,166Nov 03 05:00 PM
Parrish JayChief Business OfficerNov 02Sale31.276,944217,153222,222Nov 03 05:00 PM
Virgin HerbertEVP, Research & CSOOct 27Option Exercise1.533,8055,82227,505Oct 28 07:43 PM
Virgin HerbertEVP, Research & CSOOct 27Sale35.043,805133,33523,700Oct 28 07:43 PM
Pang PhillipChief Medical OfficerOct 21Option Exercise2.2112,50027,66742,277Oct 22 06:15 PM
Pang PhillipChief Medical OfficerOct 21Sale35.4912,500443,60829,777Oct 22 06:15 PM
Pang PhillipChief Medical OfficerOct 21Sale31.445,000157,20929,777Nov 05 05:00 PM
Virgin HerbertEVP, Research & CSOOct 13Option Exercise1.535,5608,50729,260Oct 14 06:33 PM
Virgin HerbertEVP, Research & CSOOct 13Sale43.035,560239,23623,700Oct 14 06:33 PM
Pang PhillipChief Medical OfficerOct 07Option Exercise1.5412,50019,22942,277Oct 08 05:00 PM
Pang PhillipChief Medical OfficerOct 07Sale41.7412,500521,79529,777Oct 08 05:00 PM
Parrish JayChief Business OfficerOct 01Option Exercise1.526,94510,522229,167Oct 02 05:19 PM
Parrish JayChief Business OfficerOct 01Sale34.756,945241,342222,222Oct 02 05:19 PM
Virgin HerbertEVP, Research & CSOSep 29Option Exercise1.533,5105,37027,210Oct 01 05:00 PM
Virgin HerbertEVP, Research & CSOSep 29Sale38.003,510133,38023,700Oct 01 05:00 PM
Virgin HerbertEVP, Research & CSOSep 24Option Exercise1.533,7005,66123,700Sep 28 05:00 PM
Virgin HerbertEVP, Research & CSOSep 22Option Exercise1.533,8055,82223,805Sep 23 05:00 PM
Virgin HerbertEVP, Research & CSOSep 22Sale31.713,805120,63820,000Sep 23 05:00 PM
Pang PhillipChief Medical OfficerSep 16Option Exercise2.2412,50028,00142,277Sep 18 05:00 PM
Pang PhillipChief Medical OfficerSep 16Sale31.9012,500398,69429,777Sep 18 05:00 PM
Virgin HerbertEVP, Research & CSOSep 08Option Exercise1.533,8055,82223,805Sep 10 04:30 PM
Virgin HerbertEVP, Research & CSOSep 08Sale29.993,805114,09820,000Sep 10 04:30 PM
Pang PhillipChief Medical OfficerSep 02Option Exercise1.5812,50019,68842,277Sep 03 04:23 PM
Pang PhillipChief Medical OfficerSep 02Sale32.8912,500411,15929,777Sep 03 04:23 PM
Parrish JayChief Business OfficerSep 01Option Exercise1.586,94310,935229,165Sep 03 04:22 PM
Parrish JayChief Business OfficerSep 01Sale39.156,943271,796222,222Sep 03 04:22 PM
Virgin HerbertEVP, Research & CSOAug 25Option Exercise1.5325,56039,10725,560Sep 10 04:29 PM
Virgin HerbertEVP, Research & CSOAug 25Sale42.925,560238,63220,000Sep 10 04:29 PM
Pang PhillipChief Medical OfficerAug 19Option Exercise1.5126,50039,99242,277Aug 21 04:39 PM
Pang PhillipChief Medical OfficerAug 19Sale50.9512,500636,85529,777Aug 21 04:39 PM
Virgin HerbertEVP, Research & CSOAug 11Option Exercise1.537,90012,0877,900Aug 12 04:30 PM
Virgin HerbertEVP, Research & CSOAug 11Sale51.087,900403,5630Aug 12 04:30 PM
Pang PhillipChief Medical OfficerAug 05Option Exercise1.5812,50019,68828,277Aug 07 05:40 PM
Pang PhillipChief Medical OfficerAug 05Option Exercise1.5812,50019,68828,277Aug 07 05:07 PM
Pang PhillipChief Medical OfficerAug 05Sale50.9012,500636,22215,777Aug 07 05:07 PM
Pang PhillipChief Medical OfficerAug 05Sale50.9012,500636,22215,777Aug 07 05:40 PM
Parrish JayChief Business OfficerAug 03Option Exercise1.5011,11016,665233,332Aug 04 05:14 PM
Parrish JayChief Business OfficerAug 03Sale47.6511,110529,404222,222Aug 04 05:14 PM
Virgin HerbertEVP, Research & CSOJul 28Option Exercise1.537,90012,0877,900Jul 30 07:28 PM
Virgin HerbertEVP, Research & CSOJul 28Option Exercise1.537,90012,0877,900Jul 30 07:03 PM
Virgin HerbertEVP, Research & CSOJul 28Sale47.997,900379,0900Jul 30 07:03 PM
Virgin HerbertEVP, Research & CSOJul 28Sale47.997,900379,0900Jul 30 07:28 PM
Pang PhillipChief Medical OfficerJul 15Option Exercise2.2412,50028,01828,277Jul 16 05:00 PM
Pang PhillipChief Medical OfficerJul 15Sale49.5312,500619,11815,777Jul 16 05:00 PM
Virgin HerbertEVP, Research & CSOJul 14Option Exercise1.537,90012,0877,900Jul 16 05:00 PM
Virgin HerbertEVP, Research & CSOJul 14Sale48.857,900385,8760Jul 16 05:00 PM
Horn HowardCFOJul 13Sale50.0630,0001,501,731177,777Jul 15 04:50 PM
Horn HowardCFOJul 02Sale40.0010,000400,000207,777Jul 02 06:42 PM
Pang PhillipChief Medical OfficerJul 01Option Exercise4.3712,50054,68728,277Jul 02 06:42 PM
Parrish JayChief Business OfficerJul 01Option Exercise1.5475,000115,792297,222Jul 02 06:43 PM
Horn HowardCFOJul 01Sale37.8410,000378,399217,777Jul 02 06:42 PM
Pang PhillipChief Medical OfficerJul 01Sale37.7812,500472,25215,777Jul 02 06:42 PM
Parrish JayChief Business OfficerJul 01Sale37.9575,0002,846,310222,222Jul 02 06:43 PM
Horn HowardCFOJun 25Sale50.0030,0001,500,000227,777Jun 26 05:00 PM
Virgin HerbertEVP, Research & CSOJun 24Option Exercise1.539,36014,3219,360Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 24Sale48.009,360449,2800Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 23Option Exercise1.535,5608,5075,560Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 23Sale38.995,560216,7780Jun 24 08:23 PM
Virgin HerbertEVP, Research & CSOJun 19Option Exercise1.533,5105,3703,510Jun 23 05:00 PM
Virgin HerbertEVP, Research & CSOJun 19Sale38.003,510133,3840Jun 23 05:00 PM
Horn HowardCFOJun 19Sale40.0010,000400,000257,777Jun 23 05:00 PM
Pang PhillipChief Medical OfficerJun 17Option Exercise5.1812,50064,68828,277Jun 18 05:00 PM
Pang PhillipChief Medical OfficerJun 17Sale37.2712,500465,81515,777Jun 18 05:00 PM
Virgin HerbertEVP, Research & CSOJun 09Option Exercise1.533,8055,8223,805Jun 11 05:00 PM
Virgin HerbertEVP, Research & CSOJun 09Sale36.283,805138,0300Jun 11 05:00 PM
Pang PhillipChief Medical OfficerJun 03Option Exercise5.1812,50064,68828,277Jun 04 04:53 PM
Pang PhillipChief Medical OfficerJun 03Sale35.0712,500438,38715,777Jun 04 04:53 PM
Parrish JayChief Business OfficerJun 01Option Exercise1.4975,000111,375297,222Jun 02 09:15 PM
Parrish JayChief Business OfficerJun 01Sale35.2275,0002,641,410222,222Jun 02 09:15 PM
Horn HowardCFOJun 01Sale35.1010,000351,038267,777Jun 02 09:14 PM
Virgin HerbertEVP, Research & CSOMay 26Option Exercise1.533,8055,8223,805May 27 05:00 PM
Virgin HerbertEVP, Research & CSOMay 26Sale34.083,805129,6740May 27 05:00 PM
Virgin HerbertEVP, Research & CSOMay 18Option Exercise1.531,7552,6851,755May 19 05:21 PM
Virgin HerbertEVP, Research & CSOMay 18Sale38.001,75566,6900May 19 05:21 PM
Parrish JayChief Business OfficerMay 14Option Exercise1.4975,000111,375297,222May 15 07:18 PM
Virgin HerbertEVP, Research & CSOMay 14Option Exercise1.533,8055,8223,805May 15 07:48 PM
Virgin HerbertEVP, Research & CSOMay 14Sale30.073,805114,4180May 15 07:48 PM
Parrish JayChief Business OfficerMay 14Sale30.0575,0002,253,885222,222May 15 07:18 PM